The spectrum and types of adverse side effects to biological immune modulators: a proposal for new classification

Area of Science:

• Immunology
• Pharmacology
• Clinical Medicine

Background:

• Biological agents like cytokines, monoclonal antibodies, and fusion proteins are increasingly used to treat diverse conditions.
• While providing marked clinical improvements, these agents are associated with various adverse side effects.
• Existing side effect classifications are inadequate for biological agents due to their unique properties.

Purpose of the Study:

• To propose a novel classification system for adverse side effects of biological agents.
• To differentiate these side effects from those of conventional chemicals and drugs.
• To aid in managing clinical features, identifying risk factors, and guiding future research.

Main Methods:

• A new classification system was developed based on the distinct characteristics of biological agents.
• The proposed classification categorizes side effects into five distinct types.
• The system differentiates reactions based on underlying mechanisms, including cytokine levels, immune responses, and cross-reactivity.

Main Results:

• Five distinct types of biological agent side effects were proposed: Type alpha (high cytokine levels), Type beta (hypersensitivity), Type gamma (immune/cytokine imbalance), Type delta (cross-reactivity), and Type epsilon (non-immune system effects).
• This classification aims to provide a framework for understanding and managing these specific adverse events.
• The proposed system is distinct from classifications used for chemical drugs.

Conclusions:

• The novel classification of biological agent side effects offers a structured approach to clinical management.
• It facilitates the identification of risk factors and directs future research in this evolving medical field.
• This system enhances the understanding and handling of adverse events associated with advanced biological therapies.